[ Price : $8.95]
Federal Register notice: FDA debars for five years Brenda K. Marmas from personally importing any drug into the U.S.[ Price : $8.95]
FDA tells Axsome Therapeutics that it will meet its inspection deadline on inspecting the companys contract manufacturing facility...[ Price : $8.95]
FDA publishes a draft guidance on the development of non-opioid analgesics for acute pain.[ Price : $8.95]
Eleven senators urge FDA to finalize its over-the-counter hearing aid rule quickly now that the public comment period has ended.[ Price : $8.95]
Three stakeholders comment on an FDA draft guidance on developing drugs to treat rhinosinusitis with nasal polyps.[ Price : $8.95]
AdvaMed says FDA should make changes to a discussion paper on 3D printing of medical devices at the point of care to explicitly in...[ Price : $8.95]
Gamida Cell initiates a rolling BLA submission for omidubicel, indicated for patients with blood cancers in need of stem cell tran...[ Price : $8.95]
FDA approves safety-related labeling changes for Allergans anti-depressant drug Celexa.